Drug Profile
Research programme: small molecule therapeutics - Oligomerix
Alternative Names: Small molecule tau inhibitors - Oligomerix; Tau Oligomer inhibitor - OligomerixLatest Information Update: 05 Jan 2023
Price :
$50
*
At a glance
- Originator OLIGOMERIX
- Class Antidementias; Small molecules
- Mechanism of Action Tau protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Alzheimer's disease
Highest Development Phases
- Preclinical Alzheimer's disease; Dementia